#1002, Dana Farber Cancer Institute

Boston, Massachusetts 02215

1 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumor

Studies at this site

• Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors — Recruiting now
• Study of RP-3500, Camonsertib, in Advanced Solid Tumors — Completed